Navigation Links
Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
Date:11/5/2007

to demonstrate the inhibitory effect of INTEGRILIN(R) on the physical characteristics of a platelet-fibrin clot.

CLEAR PLATELETS 2 builds on the results of the original CLEAR PLATELETS study, which demonstrated that adding INTEGRILIN(R) to a 300-mg loading dose of clopidogrel produced greater platelet inhibition and reduced cardiac biomarkers than clopidogrel alone in patients undergoing elective stenting. Data from this study were presented at the 2004 American Heart Association Scientific Sessions. CLEAR PLATELETS 2 was an investigator-initiated study funded by Schering-Plough.

About Sinai Hospital of Baltimore

Sinai Hospital of Baltimore is a member of LifeBridge Health, a regional health organization, which includes Northwest Hospital Center, Levindale Hebrew Geriatric Center and Hospital, Jewish Convalescent & Nursing Home and related subsidiaries and affiliates.

About INTEGRILIN(R) Injection

INTEGRILIN(R) is indicated for the treatment of patients with acute coronary syndrome (unstable angina/non-ST-segment-elevation myocardial infarction), including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI). It is also indicated in the United States for the treatment of patients at time of PCI, including in patients undergoing intracoronary stenting.

INTEGRILIN(R) is contraindicated in patients with a history of bleeding diathesis, or evidence of abnormal bleeding within the previous 30 days; severe hypertension (systolic blood pressure greater than 200 mm Hg or diastolic blood pressure greater than 110 mm Hg) not adequately controlled on antihypertensive therapy; major surgery within the preceding six weeks; history of stroke within 30 days, or any history of hemorrhagic stroke; current or planned administration of another parenteral GP IIb-IIIa inhibitor; dependency on renal dialysis; or known hypersensitivity to any component of the product.

Bleeding is the most common co
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
3. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
4. PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
5. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
6. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
7. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
10. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
11. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Invivotek L.L.C., a member of the ... that its animal research facility was awarded full ... Accreditation of Laboratory Animal Care International (AAALAC). AAALAC ... worldwide through voluntary accreditation and assessment programs. AAALAC ... use in 38 countries. Invivotek was ...
(Date:7/14/2014)... 14, 2014 Valeant Pharmaceuticals International, Inc. ... today announced it has filed a premerger notification ... (HSR) with the U.S. Federal Trade Commission (FTC) ... (NYSE: AGN). About Valeant Pharmaceuticals ... Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical ...
(Date:7/14/2014)... , July 14, 2014  Mallinckrodt plc (NYSE: ... QCOR ) today announced that the registration statement on Form ... by Mallinckrodt plc on May 16, 2014 and amended on ... Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt, ... on Form S-4 is available on the SEC,s EDGAR system, ...
Breaking Medicine Technology:Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 3Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 4Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 6Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 7
... WASHINGTON, Sept. 19 The Richard B. and ... Birch McCormick,Genomics Center at The George Washington ... the issues and implications around the growing ... This symposium is,intended to provide a valuable ...
... Mich., Sept. 19 A new topical lotion ... eliminate serious skin,infections, but without being systemically absorbed, ... in patients with onychomycosis, or,toenail fungus, a new ... 1 clinical trial are important to the fields ...
Cached Medicine Technology:Personalized Medicine - The Genomic Revolution in Cardiac Care 2Personalized Medicine - The Genomic Revolution in Cardiac Care 3New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 2New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 3
(Date:7/14/2014)... Last month Bromell Agency officially launched the ... features more detailed information on how clients can protect ... and boats in the state of Louisiana. , The ... the website in order to better educate clients on ... of the website, which is to display comprehensive insurance ...
(Date:7/14/2014)... Academy, senescent is he who "begins to age". But ... is senescence not a synonym of ageing, it is ... is such a badly named physiological process that those ... another name. That is the case of Manuel Serrano, ... of the world,s leading experts on senescence, who has ...
(Date:7/14/2014)... 2014 Physical fitness may buffer some of the adverse ... new study by researchers from the American Cancer Society, ... study appears in the journal Mayo Clinic Proceeding ... and obesity and blood markers associated with cardiovascular disease ... , Sedentary behavior has been linked to an increase ...
(Date:7/14/2014)... Botanica Day Spa announced last month that their ... the day spa in down town Clearwater, FL on ... refreshments will be served as clients are invited to ... and great deals on spa services, including the ... (also known as “facial shaving”) is a simple and ...
(Date:7/14/2014)... -- Being physically active in middle age appears to ... types of dementia, suggest the findings from two new ... exercise at various levels, especially in midlife, is beneficial ... Clinic, said in an Alzheimer,s Association news release. ... conclusive. More research is needed to determine the extent ...
Breaking Medicine News(10 mins):Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3Health News:Physical fitness associated with less pronounced effect of sedentary behavior 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Staying Active May Help Prevent Dementia 2
... Food and Drug Administration,s (FDA) recent decision to approve ... treatment of non-Hodgkin,s lymphoma (NHL). "This is ... M. Graham, M.D., Ph.D., president of SNM and director ... College of Medicine. "We,ve known for some time that ...
... , ... superstore has beaten the thirty cents per card - three day production threshold on quantities ... Fort ... so few plastic cards so fast and at this price level. This is a special ...
... , , Members Take to ... with Constituent Health Care Stories to Congress , ... health care reform speech, and with Congress back to work in Washington, AARP ... what,s broken and preserve what,s right. , , ...
... , BELGRADE, Serbia, Sept. 10 /PRNewswire-FirstCall/ - HTDS ... its operating subsidiary Slavica Bio Chem www.slavicabiochem.com ... , , The equipment is ... http://www.expressionproteomics.com/LifeScience/pdf/Bulletin_3095.pdf , , , Dr.Ivana Gadjanski HTDS ...
... TEANECK, N.J., Sept. 10 After an 8 day trial, ... on September 4, 2009 by the Superior Court of New Jersey ... breaching her duty of loyalty. , , ... 2009, Ellen Koblitz, Presiding Judge of the Superior Court of New ...
... WALTHAM, Mass., Sept. 10 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger of ... several healthcare industry investor conferences during the month of September. , ... Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend ...
Cached Medicine News:Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:My1Stop.com Offers Plastic Card Printing Promotion Beats the Thirty Cents per Card Threshold - Offering 1000 Cards in Only Three Days for $299 2Health News:AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago 2Health News:Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects 2Health News:Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects 3Health News:Inverness Medical Innovations Announces September Investor Conference Schedule 2
... The VersaPulse® PowerSuite™ holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
... Cemex features a unique self-contained ... clinically proven in Europe for ... integrating bone cement powder and ... system, Cemex is designed to ...
Medicine Products: